Compositions and method for treating epilepsy and convulsions

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3113

Patent

active

040040291

ABSTRACT:
Compounds of the formula ##STR1## wherein R.sub.1 and R.sub.2 are each hydrogen or lower alkyl, R.sub.3 represents lower alkyl and A is a monovalent group of formula: ##STR2## wherein Y is hydrogen or the acyl radical of a hydrocarbon carboxylic acid having from 2 to 18 carbon atoms, inclusive, are employed as anticonvulsants in treating mammals, including humans.
Novel compounds within the scope of the above formula are also disclosed, wherein R.sub.1 is specifically lower alkyl and provided that R.sub.1 is located in a position ortho or meta to the substituent group A when R.sub.2 is hydrogen. Disclosed also are novel intermediate compounds for preparing the above-described novel compounds of the invention, which correspond thereto but wherein the group A is replaced by a nitro-group.

REFERENCES:
patent: 3293252 (1966-12-01), Fried et al.
"Anti-Ulcer Agents," Moffett et al., J. Med. Chem., vol. 14, pp. 963-968 (1971).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Compositions and method for treating epilepsy and convulsions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and method for treating epilepsy and convulsions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and method for treating epilepsy and convulsions will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-72996

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.